InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
18,958.40
(
-1.30%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
85.27
(
1.49%
)
Bitcoin
60,082.45
(
-4.87%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Inoviorulez

Send PM Follow Ignore
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Inoviorulez

Re: Sil post# 74655

Thursday, 05/23/2013 7:35:46 PM

Thursday, May 23, 2013 7:35:46 PM

Post# of 158400
BMSN has something good going. For a company with 2 IND's , one in stem cell research and another in Breast cancer immunotherapy, it is still cheap.

BMSN is the real deal. here is some Due diligence for investors!

http://www.marketwatch.com/story/regen-biopharma-receives-ind-from-fda-for-hemaxellerate-2013-03-18
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up